Good morning, everyone, and how are you today? We hope the weekend was invigorating and relaxing. Now, though, the time has come to resume that blessed routine of meetings and deadlines. To cope, yes, we are quaffing a few cups of stimulation - Golden French Toast is a delicious alternative today. Please join us. And to further help you along, we have assembled a few tidbits to keep you abreast of your world at large. Hope your day goes well and you accomplish much. Good luck and stay in touch...
FDA Approves Roche Skin Cancer Drug (TheStreet)
Cell Therapeutics Pulls Drug After CEO Boasts About Approval (TheStreet)
Teva's Cephalon Unit Recalls Treanda Over Glass Fragments (Globes)
Gardasil Is Not Linked To Autoimmune Disorders: Study (Medical News Today)
Novartis Axes 150 Temp Workers At Troubled Plant (WOWT)
Medicaid Drug Rules Saves US $18 Billion (Bloomberg News)
J&J Recalls Aveeno Baby Lotion Over Bacteria (Reuters)
Pfizer And Teva Eye Buying Out Micro Labs (VCCircle)
Russian Trial Approvals Rise, But Reviews Remain Slow (Outsourcing Pharma)
FDA Approves Pfizer Inlyta For Advanced Kidney Cancer (Associated Press)
J&J Looks To Reopen Pennsylvania Plant In 2013 (Montgomery Media)
IV Acetaminophen Leads To More Overdoses Among Children (HealthDay)
EDITOR'S NOTE: Please check this post for updates throughout the morning
steaming coffee thx to dleggett on flickr